References
- Geyer MA , VollenweiderFX. Serotonin research: contributions to understanding psychoses. Trends Pharmacol. Sci.29 , 445–453 (2008).
- Arranz MJ , de Leon J. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research. Mol. Psychiatry12 , 707–747 (2007).
- Gray L , ScarrE, DeanB. Serotonin 1a receptor and associated G-protein activation in schizophrenia and bipolar disorder. Psychiatry Res.143 , 111–120 (2006).
- Tsuang MT , TaylorL, FaraoneSV. An overview of the genetics of psychotic mood disorders. J. Psychiatr. Res.38 , 3–15 (2004).
- Roth TL , LubinFD, SodhiM, KleinmanJE. Epigenetic mechanisms in schizophrenia. Biochim. Biophys. Acta1790 , 869–877 (2009).
- Pidsley R , MillJ. Epigenetic studies of psychosis: current findings, methodological approaches, and implications for postmortem research. Biol. Psychiatry69 , 146–156 (2011).
- Abdolmaleky HM , YaqubiS, PapageorgisPet al. Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder. Schizophr. Res. 129 , 183–190 (2011).
- Carrard A , SalzmannA, MalafosseA, KaregeF. Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder. J. Affect Disord.132 , 450–453 (2011).
- Ghadirivasfi M , NohesaraS, AhmadkhanihaHRet al. Hypomethylation of the serotonin receptor type-2A gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 156 , 536–545 (2011).
- Jaenisch R , BirdA. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet.33(Suppl.) , 245–254 (2003).
- Craddock N , O‘DonovanMC, OwenMJ. Psychosis genetics: modeling the relationship between schizophrenia, bipolar disorder, and mixed (or “schizoaffective”) psychoses. Schizophr. Bull.35 , 482–490 (2009).